NUKL:XETRA:XETRA-VanEck Uranium and Nuclear Technologies UCITS ETF A USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 33.65

Change

+0.56 (+1.69)%

Market Cap

USD 0.34B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.16 (+0.29%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.10%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.09 (+0.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.25 (+0.98%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.35 (+0.75%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

+0.74 (+0.53%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.18 (+0.35%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.68 (+0.63%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.84 (+0.62%)

USD 80.38B

ETFs Containing NUKL:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.27% 90% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.27% 90% A- 85% B
Trailing 12 Months  
Capital Gain 32.48% 90% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.48% 90% A- 87% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 14.32% 79% B- 77% C+
Dividend Return 14.32% 78% C+ 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.24% 19% F 31% F
Risk Adjusted Return 70.73% 60% D- 65% D
Market Capitalization 0.34B 57% F 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.